DOD Amyotrophic Lateral Sclerosis, Therapeutic Development Award
The FY25 Amyotrophic Lateral Sclerosis Research Program (ALSRP) Therapeutic Development Award supports research advancing from preclinical validation to FDA IND-enabling studies for ALS therapies. Proposals should be empirical, product-driven, and involve collaborators with significant ALS expertise. Applicants must begin with lead compounds and proof-of-concept efficacy data from preclinical …
Summary: The fiscal year 2025 (FY25) Amyotrophic Lateral Sclerosis Research Program (ALSRP) Therapeutic Development Award (TDA) supports research ranging from preclinical validation of therapeutic leads through Food and Drug Administration (FDA) Investigational New Drug (IND)-en…
Funding Source
Awards & funding
Eligibility
Dates
Supporting links
Documents
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers